Glaucoma-Intraocular Pressure Reduction

Author(s):  
Alex S. Huang ◽  
Lilit Minasyan ◽  
Robert N. Weinreb



2016 ◽  
pp. 757 ◽  
Author(s):  
Shamira Perera ◽  
Monisha Nongpiur ◽  
Paul Chew ◽  
Maria Cecilia Aquino ◽  
Chelvin Sng ◽  
...  


Ophthalmology ◽  
2010 ◽  
Vol 117 (11) ◽  
pp. 2061-2066 ◽  
Author(s):  
Felipe A. Medeiros ◽  
Luciana M. Alencar ◽  
Pamela A. Sample ◽  
Linda M. Zangwill ◽  
Remo Susanna Jr. ◽  
...  


2021 ◽  
Vol 10 (4) ◽  
pp. 2
Author(s):  
Ana Marie L. Rubenicia ◽  
Leo D. P. Cubillan ◽  
Victor Arni D. P. Sicam ◽  
Allan Patrick G. Macabeo ◽  
Oliver B. Villaflores ◽  
...  


1970 ◽  
Vol 54 (12) ◽  
pp. 801-804 ◽  
Author(s):  
R. Robbins ◽  
A. S. Obstbaum ◽  
M. Best ◽  
M. A. Galin


Author(s):  
Alan D. Penman ◽  
Kimberly W. Crowder ◽  
William M. Watkins

The Collaborative Normal-Tension Glaucoma Study (CNTGS) was a randomized clinical trial to determine the effectiveness of a 30% reduction in intraocular pressure (IOP) (using either medical therapy or filtration surgery) on visual field (VF) progression in eyes with normal-tension glaucoma. The study found that reducing the IOP of patients with normal-tension glaucoma by 30% is beneficial to prevent progression of glaucomatous damage if the visual effects of cataracts are excluded from consideration. However, because not all untreated patients progressed, the natural history of normal-tension glaucoma must be considered before embarking on IOP reduction with therapy that may exacerbate cataract formation, unless normal-tension glaucoma threatens serious visual loss.



Sign in / Sign up

Export Citation Format

Share Document